{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T15:25:07Z","timestamp":1759937107811},"publisher-location":"Vienna","reference-count":30,"publisher":"Springer Vienna","isbn-type":[{"type":"print","value":"9783211825419"},{"type":"electronic","value":"9783709166413"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1994]]},"DOI":"10.1007\/978-3-7091-6641-3_21","type":"book-chapter","created":{"date-parts":[[2012,10,6]],"date-time":"2012-10-06T01:17:35Z","timestamp":1349486255000},"page":"275-281","source":"Crossref","is-referenced-by-count":2,"title":["Cholinergic approaches to the treatment of progressive supranuclear palsy"],"prefix":"10.1007","author":[{"given":"I.","family":"Litvan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"21_CR1","first-page":"191","volume-title":"Advances in neurology","author":"Y Agid","year":"1986","unstructured":"Agid Y, Javoy-Agid F, Ruberg M, Pillon B, Dubois B, Duyckaerts C, Hauw JJ, Baron JC, Scatton B (1986) Progressive supranuclear palsy: anatomoclinical and biochemical considerations. In: Yahr MD, Bergmann KJ (eds) Advances in neurology, vol 45. Raven Press, New York, pp 191\u2013206."},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1136\/jnnp.54.9.832","volume":"54","author":"JR Atack","year":"1991","unstructured":"Atack JR, Litvan I, Thal LJ, May C, Rapaport SI, Chase TN (1991) Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine. J Neurol Neurosurg Psychiatry 54: 832\u2013835.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"21_CR3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0306-4522(91)90197-V","volume":"41","author":"JP Brandel","year":"1991","unstructured":"Brandel JP, Hirsch EC, Malessa S, Duyckaerts C, Cervera P, Agid Y (1991) Differential vulnerability of cholinergic projections to the mediodorsal nucleus of the thalamus in senile dementia of Alzheimer type and progressive supranuclear palsy. Neuroscience 41: 25\u201331.","journal-title":"Neuroscience"},{"key":"21_CR4","first-page":"15","volume":"39","author":"J Brown","year":"1958","unstructured":"Brown J (1958) Some test of decay theory of immediate memory. Q J Exp Psychol 39: 15\u201322.","journal-title":"Q J Exp Psychol"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1212\/WNL.24.11.1019","volume":"24","author":"H Buschke","year":"1974","unstructured":"Buschke H, Altman Fuld P (1974) Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 24: 1019\u20131025.","journal-title":"Neurology"},{"key":"21_CR6","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1001\/archneur.1967.00470260014002","volume":"17","author":"RC Duvoisin","year":"1967","unstructured":"Duvoisin RC (1967) Cholinergic-anticholinergic antagonism in parkinsonism. Arch Neurol 17: 124\u2013136.","journal-title":"Arch Neurol"},{"key":"21_CR7","unstructured":"Duvoisin R (1992) Clinical diagnosis. In: Litvan I, Agid Y (eds) Progressive supranuclear palsy: clinical and research approaches. Oxford University Press, pp 15-33."},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1212\/WNL.39.2.257","volume":"39","author":"NL Foster","year":"1989","unstructured":"Foster NL, Aldrich MS, Bluemlein MS, White RF, Berent S (1989) Failure of cholinergic agonist RS-86 to improve cognition and movement in PSP despite effects on sleep. Neurology 39: 257\u2013261.","journal-title":"Neurology"},{"key":"21_CR9","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/978-1-4899-6738-1_29","volume-title":"Cholinergic basis for Alzheimer therapy","author":"E Giacobini","year":"1991","unstructured":"Giacobini E (1991) The second generation of cholinesterase inhibitors: pharmacological aspects. In: Becker R, Giacobini E (eds) Cholinergic basis for Alzheimer therapy. Birkh\u00e4user, Boston, pp 247\u2013262."},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1001\/archneur.1990.00530050077015","volume":"47","author":"J Grafman","year":"1990","unstructured":"Grafman J, Litvan I, Gomez C, Chase TN (1990) Frontal lobe function in progressive supranuclear palsy. Arch Neurol 47: 553\u2013558.","journal-title":"Arch Neurol"},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/0304-3940(90)90829-X","volume":"119","author":"JJ Hauw","year":"1990","unstructured":"Hauw JJ, Verny M, Delaere P, Cervera P, He Y, Duyckaerts C (1990) Constant neurofibrillary changes in the neocortex in progressive supranuclear palsy. Basic differences with Alzheimer\u2019s disease and aging. Neurosci Lett 119: 182\u2013186.","journal-title":"Neurosci Lett"},{"key":"21_CR12","doi-asserted-by":"publisher","first-page":"5976","DOI":"10.1073\/pnas.84.16.5976","volume":"84","author":"EC Hirsch","year":"1987","unstructured":"Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci USA 84: 5976\u20135980.","journal-title":"Proc Natl Acad Sci USA"},{"key":"21_CR13","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1136\/jnnp.51.4.540","volume":"51","author":"K Jellinger","year":"1988","unstructured":"Jellinger K (1988) The pedunculopontine nucleus in Parkinson\u2019s disease, progressive supranuclear palsy and Alzheimer\u2019s disease. J Neurol Neurosurg Psychiatry 51: 540\u2013543.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1212\/WNL.41.1.25","volume":"41","author":"JL Juncos","year":"1991","unstructured":"Juncos JL, Hirsch EC, Malessa S, Duyckaerts C, Hersh LB, Agid Y (1991) Mesencephalic cholinergic nuclei in progressive supranuclear palsy. Neurology 41: 25\u201330.","journal-title":"Neurology"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1002\/ana.410180504","volume":"18","author":"SJ Kish","year":"1985","unstructured":"Kish SJ, Chang LJ, Mirchandani L, Shannak K, Hornykiewicz O (1985) Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers. Ann Neurol 18: 530\u2013536.","journal-title":"Ann Neurol"},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1001\/archneur.1990.00530120092016","volume":"47","author":"C Kertzman","year":"1990","unstructured":"Kertzman C, Robinson DL, Litvan I (1990) Effects of physostigmine on spatial attention in patients with progressive supranuclear palsy. Arch Neurol 47: 1346\u20131350.","journal-title":"Arch Neurol"},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00002826-198904000-00003","volume":"12","author":"WC Koller","year":"1989","unstructured":"Koller WC, Glatt S, Vetere-Overfield B, Hassanein R (1989) Falls and Parkinson\u2019s disease. Clin Neuropharmacol 12: 98\u2013105.","journal-title":"Clin Neuropharmacol"},{"key":"21_CR18","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1002\/ana.410260318","volume":"26","author":"I Litvan","year":"1989","unstructured":"Litvan I, Gomez C, Atack JR, Gillespie M, Kask A, Mouradian MM, Chase TN (1989) Physostigmine treatment of progressive supranuclear palsy. Ann Neurol 26: 404\u2013407.","journal-title":"Ann Neurol"},{"key":"21_CR19","first-page":"254","volume-title":"Progressive supranuclear palsy: clinical and research approaches","author":"I Litvan","year":"1992","unstructured":"Litvan I, Chase TN (1992) Traditional and expeRImental therapeutic approaches. In: Litvan I, Agid Y (eds) Progressive supranuclear palsy: clinical and research approaches. Oxford University Press, New York, pp 254\u2013269."},{"key":"21_CR20","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1212\/WNL.41.10.1593","volume":"41","author":"S Malessa","year":"1991","unstructured":"Malessa S, Hirsch EC, Cervera P, Javoy-Agid F, Duyckaerts C, Hauw JJ, Agid Y (1991) Progressive supranuclear palsy: loss of choline acetyltransferase-like im-munoreactive neurons in the pontine reticular formation. Neurology 41: 1593\u20131597.","journal-title":"Neurology"},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/978-1-4899-6738-1_11","volume-title":"Cholinergic basis for Alzheimer therapy","author":"M Marchi","year":"1991","unstructured":"Marchi M, Besana E, Codignola A (1991) Presynaptic cholinergic mechanisms in human cerebral cortex of adult and aged patients. In: Becker R, Giacobini E (eds) Cholinergic basis for Alzheimer therapy. Birkh\u00e4user, Boston, pp 92\u201397."},{"key":"21_CR22","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0022-510X(88)90106-2","volume":"86","author":"L Pierot","year":"1988","unstructured":"Pierot L, Desnos C, Blin J, Raisman R, Scherman D, Javoy-Agid F, Ruberg M, Agid Y (1988) D1 and D2-type dopamine receptors in patients with Parkinson\u2019s disease and progressive supranuclear palsy. J Neurol Sci 86: 291\u2013306.","journal-title":"J Neurol Sci"},{"key":"21_CR23","first-page":"294","volume-title":"International symposium on muscarinic cholinergic mechanisms","author":"LT Potter","year":"1987","unstructured":"Potter LT (1987) Muscarinic receptors in the cortex and hippocampus in relation to the treatment of Alzheimer\u2019s disease. In: Cohen S, Sokolovsky M (eds) International symposium on muscarinic cholinergic mechanisms. Freud Publishing Ltd, London, pp 294\u2013301."},{"key":"21_CR24","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1093\/brain\/111.2.267","volume":"111","author":"RD Rafal","year":"1988","unstructured":"Rafal RD, Posner MI, Friedman JH, Inhoff A, Bernstein E (1988) Orienting of visual attention in progressive supranuclear palsy. Brain 111: 267\u2013280.","journal-title":"Brain"},{"key":"21_CR25","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/ana.410180503","volume":"18","author":"M Ruberg","year":"1985","unstructured":"Ruberg M, Javoy-Agid F, Hirsch E, Scatton B, Lheureux R, Hauw JJ, Duyckaerts C, Gray F, Morel-Maroger A, Rascol A, Serdaru M, Agid Y (1985) Dopaminergic and cholinergic lesions in progressive supranuclear palsy. Ann Neurol 18: 523\u2013529.","journal-title":"Ann Neurol"},{"key":"21_CR26","first-page":"89","volume-title":"Progressive supranuclear palsy: clinical and research approaches","author":"M Ruberg","year":"1992","unstructured":"Ruberg M, Hirsch E, Javoy-Agid F (1992) Neurochemistry. In: Litvan I, Agid Y (eds) Progressive supranuclear palsy: clinical and research approaches. Oxford University Press, New York, pp 89\u2013109."},{"key":"21_CR27","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1001\/archneur.1964.00460160003001","volume":"10","author":"JC Steele","year":"1964","unstructured":"Steele JC, Richardson JC, Olszewski J (1964) Progressive supranuclear palsy: a heterogeneous degeneration involving the brain stem, basal ganglia, and cerebellum, with vertical gaze and pseudobulbar palsy, nuclear dystonia, and dementia. Arch Neurol 10: 333\u2013359.","journal-title":"Arch Neurol"},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1532-5415.1989.tb01567.x","volume":"37","author":"LJ Thal","year":"1983","unstructured":"Thal LJ, Fuld PA, Masur DM, Sharpless NS (1983) Oral physostigmine without lecithin improves memory in Alzheimer\u2019s disease. J Am Geriatr Soc 37: 42\u201348.","journal-title":"J Am Geriatr Soc"},{"key":"21_CR29","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/BF00697397","volume":"61","author":"F Tagliavini","year":"1983","unstructured":"Tagliavini F, Pilleri G, Gemignani F, Lechi A (1983) Neuronal loss in the basal nucleus of Meynert in progressive supranuclear palsy. Acta Neuropathol 61: 157\u2013160.","journal-title":"Acta Neuropathol"},{"key":"21_CR30","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1073\/pnas.87.18.7050","volume":"87","author":"DM Weiner","year":"1990","unstructured":"Weiner DM, Levey AI, Brann MR (1990) Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci USA 87: 7050\u20137054.","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Journal of Neural Transmission. Supplementa","Progressive Supranuclear Palsy: Diagnosis, Pathology, and Therapy"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-6641-3_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,8]],"date-time":"2019-05-08T04:18:27Z","timestamp":1557289107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-7091-6641-3_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994]]},"ISBN":["9783211825419","9783709166413"],"references-count":30,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-6641-3_21","relation":{},"ISSN":["0303-6995"],"issn-type":[{"type":"print","value":"0303-6995"}],"subject":[],"published":{"date-parts":[[1994]]}}}